A comprehensive view of Injectables / Infusions / IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Medincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies; deal includes development of up to six injectables across multiple therapeutic areas

Three US Senators to question Novo Nordisk over the discontinuation of Levemir, a long-acting insulin, just before a significant price cut was due to take effect; over seven million patients in the US rely on insulin

Phase 3 study of Roche's OCREVUS subcutaneous injection shows near-complete suppression of multiple sclerosis relapse activity and lesions; approval anticipated from FDA and EMA in 2024

Eli Lilly reports tirzepatide injectable significantly reduced sleep apnea in Phase 3 trials, achieving up to 63% reduction in the apnea-hypopnea index, a measure of sleep apnea severity; the drug also led to significant weight loss

US Senator Bernie Sanders urges Novo Nordisk to reduce prices of Ozempic and Wegovy, citing high costs could bankrupt Medicare; Novo Nordisk says public debate overlooks complex reality of drug development, remains committed to affordable medications

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count